Reference
Kemp-Casey A, et al. Using Post-market Utilisation Analysis to Support Medicines Pricing Policy: An Australian Case Study of Aflibercept and Ranibizumab Use. Applied Health Economics and Health Policy : 25 Oct 2018. Available from: URL: http://doi.org/10.1007/s40258-018-0440-4
Rights and permissions
About this article
Cite this article
Utilisation supports same price for aflibercept and ranibizumab. PharmacoEcon Outcomes News 816, 33 (2018). https://doi.org/10.1007/s40274-018-5453-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5453-6